KR20020018844A - The uncooked food for glucose control of a diabetic and method of manufacture - Google Patents
The uncooked food for glucose control of a diabetic and method of manufacture Download PDFInfo
- Publication number
- KR20020018844A KR20020018844A KR1020000052140A KR20000052140A KR20020018844A KR 20020018844 A KR20020018844 A KR 20020018844A KR 1020000052140 A KR1020000052140 A KR 1020000052140A KR 20000052140 A KR20000052140 A KR 20000052140A KR 20020018844 A KR20020018844 A KR 20020018844A
- Authority
- KR
- South Korea
- Prior art keywords
- vitamin
- raw
- ratio
- brown rice
- seaweed
- Prior art date
Links
- 235000013305 food Nutrition 0.000 title claims abstract description 42
- 206010012601 diabetes mellitus Diseases 0.000 title claims description 54
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 title claims description 19
- 239000008103 glucose Substances 0.000 title claims description 19
- 238000004519 manufacturing process Methods 0.000 title claims description 12
- 238000000034 method Methods 0.000 title claims description 11
- 210000004369 blood Anatomy 0.000 claims abstract description 30
- 239000008280 blood Substances 0.000 claims abstract description 30
- 241001474374 Blennius Species 0.000 claims abstract description 21
- 235000013339 cereals Nutrition 0.000 claims abstract description 21
- 235000021329 brown rice Nutrition 0.000 claims abstract description 20
- 239000000203 mixture Substances 0.000 claims abstract description 16
- 235000013311 vegetables Nutrition 0.000 claims abstract description 16
- 235000001674 Agaricus brunnescens Nutrition 0.000 claims abstract description 15
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims abstract description 12
- 241000233866 Fungi Species 0.000 claims abstract description 11
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims abstract description 10
- 240000007594 Oryza sativa Species 0.000 claims abstract description 9
- 235000007164 Oryza sativa Nutrition 0.000 claims abstract description 9
- 235000009566 rice Nutrition 0.000 claims abstract description 9
- 241000894006 Bacteria Species 0.000 claims abstract description 7
- 241000195649 Chlorella <Chlorellales> Species 0.000 claims abstract description 7
- 235000021307 Triticum Nutrition 0.000 claims abstract description 7
- 244000098338 Triticum aestivum Species 0.000 claims abstract description 7
- 229940109850 royal jelly Drugs 0.000 claims abstract description 7
- 241000255789 Bombyx mori Species 0.000 claims abstract description 6
- 240000007124 Brassica oleracea Species 0.000 claims abstract description 6
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 claims abstract description 6
- 235000012905 Brassica oleracea var viridis Nutrition 0.000 claims abstract description 6
- 240000000249 Morus alba Species 0.000 claims abstract description 6
- 235000008708 Morus alba Nutrition 0.000 claims abstract description 6
- 235000008331 Pinus X rigitaeda Nutrition 0.000 claims abstract description 6
- 235000011613 Pinus brutia Nutrition 0.000 claims abstract description 6
- 241000018646 Pinus brutia Species 0.000 claims abstract description 6
- 235000014655 lactic acid Nutrition 0.000 claims abstract description 6
- 239000004310 lactic acid Substances 0.000 claims abstract description 6
- 244000066764 Ailanthus triphysa Species 0.000 claims abstract description 5
- 240000005528 Arctium lappa Species 0.000 claims abstract description 5
- 235000003130 Arctium lappa Nutrition 0.000 claims abstract description 5
- 235000008078 Arctium minus Nutrition 0.000 claims abstract description 5
- 235000000832 Ayote Nutrition 0.000 claims abstract description 5
- 241001107116 Castanospermum australe Species 0.000 claims abstract description 5
- 235000009854 Cucurbita moschata Nutrition 0.000 claims abstract description 5
- 235000009804 Cucurbita pepo subsp pepo Nutrition 0.000 claims abstract description 5
- 235000002767 Daucus carota Nutrition 0.000 claims abstract description 5
- 244000000626 Daucus carota Species 0.000 claims abstract description 5
- 240000008397 Ganoderma lucidum Species 0.000 claims abstract description 5
- 235000001637 Ganoderma lucidum Nutrition 0.000 claims abstract description 5
- 240000005979 Hordeum vulgare Species 0.000 claims abstract description 5
- 235000007340 Hordeum vulgare Nutrition 0.000 claims abstract description 5
- 244000061456 Solanum tuberosum Species 0.000 claims abstract description 5
- 235000002595 Solanum tuberosum Nutrition 0.000 claims abstract description 5
- 235000011684 Sorghum saccharatum Nutrition 0.000 claims abstract description 5
- 235000021279 black bean Nutrition 0.000 claims abstract description 5
- 235000007215 black sesame Nutrition 0.000 claims abstract description 5
- 235000015136 pumpkin Nutrition 0.000 claims abstract description 5
- 240000004244 Cucurbita moschata Species 0.000 claims abstract description 3
- 235000005911 diet Nutrition 0.000 claims description 38
- 239000002994 raw material Substances 0.000 claims description 36
- 230000037213 diet Effects 0.000 claims description 31
- 238000002156 mixing Methods 0.000 claims description 15
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 13
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 12
- 241000220259 Raphanus Species 0.000 claims description 11
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 claims description 11
- 241000196324 Embryophyta Species 0.000 claims description 10
- 235000018102 proteins Nutrition 0.000 claims description 10
- 102000004169 proteins and genes Human genes 0.000 claims description 10
- 108090000623 proteins and genes Proteins 0.000 claims description 10
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims description 8
- 239000012856 weighed raw material Substances 0.000 claims description 8
- 150000001720 carbohydrates Chemical class 0.000 claims description 7
- 235000014633 carbohydrates Nutrition 0.000 claims description 7
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 6
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 6
- 229930003268 Vitamin C Natural products 0.000 claims description 6
- 229930003427 Vitamin E Natural products 0.000 claims description 6
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 claims description 6
- 239000011575 calcium Substances 0.000 claims description 6
- 229910052791 calcium Inorganic materials 0.000 claims description 6
- 238000013329 compounding Methods 0.000 claims description 6
- 235000019197 fats Nutrition 0.000 claims description 6
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 6
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 6
- 239000004615 ingredient Substances 0.000 claims description 6
- 235000019154 vitamin C Nutrition 0.000 claims description 6
- 239000011718 vitamin C Substances 0.000 claims description 6
- 239000011709 vitamin E Substances 0.000 claims description 6
- 235000019165 vitamin E Nutrition 0.000 claims description 6
- 229940046009 vitamin E Drugs 0.000 claims description 6
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 5
- 241000512259 Ascophyllum nodosum Species 0.000 claims description 5
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims description 5
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 5
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 5
- 229930003451 Vitamin B1 Natural products 0.000 claims description 5
- 229930003471 Vitamin B2 Natural products 0.000 claims description 5
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 5
- 238000004108 freeze drying Methods 0.000 claims description 5
- 239000000845 maltitol Substances 0.000 claims description 5
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 claims description 5
- 229940035436 maltitol Drugs 0.000 claims description 5
- 235000010449 maltitol Nutrition 0.000 claims description 5
- 229960002477 riboflavin Drugs 0.000 claims description 5
- 150000003839 salts Chemical class 0.000 claims description 5
- 229960003495 thiamine Drugs 0.000 claims description 5
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims description 5
- 235000019155 vitamin A Nutrition 0.000 claims description 5
- 239000011719 vitamin A Substances 0.000 claims description 5
- 235000010374 vitamin B1 Nutrition 0.000 claims description 5
- 239000011691 vitamin B1 Substances 0.000 claims description 5
- 235000019164 vitamin B2 Nutrition 0.000 claims description 5
- 239000011716 vitamin B2 Substances 0.000 claims description 5
- 229940045997 vitamin a Drugs 0.000 claims description 5
- 240000004307 Citrus medica Species 0.000 claims description 4
- 241000195493 Cryptophyta Species 0.000 claims description 4
- 244000241838 Lycium barbarum Species 0.000 claims description 4
- 235000015459 Lycium barbarum Nutrition 0.000 claims description 4
- 240000002853 Nelumbo nucifera Species 0.000 claims description 4
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims description 4
- 240000003829 Sorghum propinquum Species 0.000 claims description 4
- 244000269722 Thea sinensis Species 0.000 claims description 4
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims description 4
- 230000035784 germination Effects 0.000 claims description 4
- 230000002641 glycemic effect Effects 0.000 claims description 4
- 238000004806 packaging method and process Methods 0.000 claims description 4
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 claims description 4
- 235000019158 vitamin B6 Nutrition 0.000 claims description 4
- 239000011726 vitamin B6 Substances 0.000 claims description 4
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 claims description 4
- 235000005282 vitamin D3 Nutrition 0.000 claims description 4
- 239000011647 vitamin D3 Substances 0.000 claims description 4
- 229940011671 vitamin b6 Drugs 0.000 claims description 4
- 229940021056 vitamin d3 Drugs 0.000 claims description 4
- YNVZDODIHZTHOZ-UHFFFAOYSA-K 2-hydroxypropanoate;iron(3+) Chemical compound [Fe+3].CC(O)C([O-])=O.CC(O)C([O-])=O.CC(O)C([O-])=O YNVZDODIHZTHOZ-UHFFFAOYSA-K 0.000 claims description 3
- 240000000599 Lentinula edodes Species 0.000 claims description 3
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims description 3
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims description 3
- 241001668545 Pascopyrum Species 0.000 claims description 3
- 235000019152 folic acid Nutrition 0.000 claims description 3
- 239000011724 folic acid Substances 0.000 claims description 3
- 229960000304 folic acid Drugs 0.000 claims description 3
- 235000001968 nicotinic acid Nutrition 0.000 claims description 3
- 229960003512 nicotinic acid Drugs 0.000 claims description 3
- 239000011664 nicotinic acid Substances 0.000 claims description 3
- 230000001105 regulatory effect Effects 0.000 claims description 3
- 239000011787 zinc oxide Substances 0.000 claims description 3
- 240000001980 Cucurbita pepo Species 0.000 claims description 2
- 238000005520 cutting process Methods 0.000 claims description 2
- 235000009569 green tea Nutrition 0.000 claims description 2
- 238000010298 pulverizing process Methods 0.000 claims description 2
- 235000002639 sodium chloride Nutrition 0.000 claims description 2
- 235000013616 tea Nutrition 0.000 claims description 2
- 235000015468 Lycium chinense Nutrition 0.000 claims 1
- 244000171263 Ribes grossularia Species 0.000 claims 1
- 235000002357 Ribes grossularia Nutrition 0.000 claims 1
- 235000021049 nutrient content Nutrition 0.000 claims 1
- 229910052500 inorganic mineral Inorganic materials 0.000 abstract description 11
- 239000011707 mineral Substances 0.000 abstract description 11
- 235000010755 mineral Nutrition 0.000 abstract description 11
- 229940088594 vitamin Drugs 0.000 abstract description 11
- 229930003231 vitamin Natural products 0.000 abstract description 11
- 235000013343 vitamin Nutrition 0.000 abstract description 11
- 239000011782 vitamin Substances 0.000 abstract description 11
- 240000002791 Brassica napus Species 0.000 abstract 2
- 235000011293 Brassica napus Nutrition 0.000 abstract 2
- 235000000540 Brassica rapa subsp rapa Nutrition 0.000 abstract 2
- 244000062793 Sorghum vulgare Species 0.000 abstract 2
- 235000008216 herbs Nutrition 0.000 abstract 2
- 241000219198 Brassica Species 0.000 abstract 1
- 235000003351 Brassica cretica Nutrition 0.000 abstract 1
- 235000003343 Brassica rupestris Nutrition 0.000 abstract 1
- 235000005979 Citrus limon Nutrition 0.000 abstract 1
- 244000131522 Citrus pyriformis Species 0.000 abstract 1
- 241000209205 Coix Species 0.000 abstract 1
- 241001466453 Laminaria Species 0.000 abstract 1
- 241001106041 Lycium Species 0.000 abstract 1
- QKSKPIVNLNLAAV-UHFFFAOYSA-N bis(2-chloroethyl) sulfide Chemical compound ClCCSCCCl QKSKPIVNLNLAAV-UHFFFAOYSA-N 0.000 abstract 1
- 235000019713 millet Nutrition 0.000 abstract 1
- 235000010460 mustard Nutrition 0.000 abstract 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 16
- 235000015097 nutrients Nutrition 0.000 description 12
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 10
- 230000000694 effects Effects 0.000 description 9
- 108010028554 LDL Cholesterol Proteins 0.000 description 7
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 7
- 230000000378 dietary effect Effects 0.000 description 7
- 235000012054 meals Nutrition 0.000 description 7
- 230000036961 partial effect Effects 0.000 description 7
- 108090000790 Enzymes Proteins 0.000 description 6
- 102000004190 Enzymes Human genes 0.000 description 6
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 6
- 238000008214 LDL Cholesterol Methods 0.000 description 6
- 235000009200 high fat diet Nutrition 0.000 description 6
- 150000002632 lipids Chemical class 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 108010023302 HDL Cholesterol Proteins 0.000 description 5
- 102000004877 Insulin Human genes 0.000 description 5
- 108090001061 Insulin Proteins 0.000 description 5
- 239000003925 fat Substances 0.000 description 5
- 229940125396 insulin Drugs 0.000 description 5
- 239000011720 vitamin B Chemical group 0.000 description 5
- 235000019156 vitamin B Nutrition 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 208000008589 Obesity Diseases 0.000 description 4
- 241000700159 Rattus Species 0.000 description 4
- 229930003270 Vitamin B Chemical group 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 235000012000 cholesterol Nutrition 0.000 description 4
- 235000018823 dietary intake Nutrition 0.000 description 4
- 230000006698 induction Effects 0.000 description 4
- 230000004060 metabolic process Effects 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 239000013589 supplement Substances 0.000 description 4
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- 235000021152 breakfast Nutrition 0.000 description 3
- 235000019804 chlorophyll Nutrition 0.000 description 3
- 229930002875 chlorophyll Natural products 0.000 description 3
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 3
- 229910052742 iron Inorganic materials 0.000 description 3
- 235000020824 obesity Nutrition 0.000 description 3
- 239000011591 potassium Substances 0.000 description 3
- 229910052700 potassium Inorganic materials 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 150000003626 triacylglycerols Chemical class 0.000 description 3
- 206010020772 Hypertension Diseases 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 108090001030 Lipoproteins Proteins 0.000 description 2
- 102000004895 Lipoproteins Human genes 0.000 description 2
- 241000199919 Phaeophyceae Species 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 239000011651 chromium Substances 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 235000013325 dietary fiber Nutrition 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 230000003914 insulin secretion Effects 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 235000008935 nutritious Nutrition 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 238000002203 pretreatment Methods 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 230000001850 reproductive effect Effects 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 235000021195 test diet Nutrition 0.000 description 2
- XDIYNQZUNSSENW-UUBOPVPUSA-N (2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanal Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O XDIYNQZUNSSENW-UUBOPVPUSA-N 0.000 description 1
- 208000021959 Abnormal metabolism Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 210000002237 B-cell of pancreatic islet Anatomy 0.000 description 1
- -1 B-complexes Chemical compound 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- LXBIFEVIBLOUGU-UHFFFAOYSA-N Deoxymannojirimycin Natural products OCC1NCC(O)C(O)C1O LXBIFEVIBLOUGU-UHFFFAOYSA-N 0.000 description 1
- 108010068370 Glutens Proteins 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 206010020710 Hyperphagia Diseases 0.000 description 1
- 102000003746 Insulin Receptor Human genes 0.000 description 1
- 108010001127 Insulin Receptor Proteins 0.000 description 1
- 235000001715 Lentinula edodes Nutrition 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 102100024295 Maltase-glucoamylase Human genes 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 240000001439 Opuntia Species 0.000 description 1
- 235000013389 Opuntia humifusa var. humifusa Nutrition 0.000 description 1
- 240000004371 Panax ginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 241000206572 Rhodophyta Species 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 108010028144 alpha-Glucosidases Proteins 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 235000019577 caloric intake Nutrition 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 235000020940 control diet Nutrition 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 235000021045 dietary change Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 102000038379 digestive enzymes Human genes 0.000 description 1
- 108091007734 digestive enzymes Proteins 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- LXBIFEVIBLOUGU-JGWLITMVSA-N duvoglustat Chemical compound OC[C@H]1NC[C@H](O)[C@@H](O)[C@@H]1O LXBIFEVIBLOUGU-JGWLITMVSA-N 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 231100000317 environmental toxin Toxicity 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000004626 essential fatty acids Nutrition 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- FODTZLFLDFKIQH-FSVGXZBPSA-N gamma-Oryzanol (TN) Chemical group C1=C(O)C(OC)=CC(\C=C\C(=O)O[C@@H]2C([C@@H]3CC[C@H]4[C@]5(C)CC[C@@H]([C@@]5(C)CC[C@@]54C[C@@]53CC2)[C@H](C)CCC=C(C)C)(C)C)=C1 FODTZLFLDFKIQH-FSVGXZBPSA-N 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 230000004153 glucose metabolism Effects 0.000 description 1
- 235000021312 gluten Nutrition 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 230000003394 haemopoietic effect Effects 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 235000001497 healthy food Nutrition 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 235000004213 low-fat Nutrition 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000006371 metabolic abnormality Effects 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 235000020830 overeating Nutrition 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 235000012015 potatoes Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 238000013222 sprague-dawley male rat Methods 0.000 description 1
- 230000007103 stamina Effects 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 208000019553 vascular disease Diseases 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
- 230000004584 weight gain Effects 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
- 235000020985 whole grains Nutrition 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical group OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L3/00—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
- A23L3/40—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by drying or kilning; Subsequent reconstitution
- A23L3/44—Freeze-drying
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/3262—Foods, ingredients or supplements having a functional effect on health having an effect on blood cholesterol
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/328—Foods, ingredients or supplements having a functional effect on health having effect on glycaemic control and diabetes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/15—Inorganic Compounds
- A23V2250/156—Mineral combination
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/70—Vitamins
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Mycology (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
본 발명은 당뇨 환자의 혈당조절 생식식품 및 그 제조방법에 관한 것이다.The present invention relates to a blood sugar regulating raw food and a method of manufacturing the same in diabetic patients.
특히, 당뇨환자(비만인 포함)들이 간편하게 이용할 수 있는 분말 형태의 생식 식품을 당뇨환자들에게 제공하여 지속적으로 복용케함으로써 당뇨 환자의 혈당을 조절할 수 있도록 하는 기술에 관한 것이다.In particular, the present invention relates to a technology for controlling the blood sugar of the diabetic patient by providing a diabetic patient with a raw raw food in a powder form that can be easily used by diabetics (including obese people).
최근 들어 식생활의 변화 및 복잡한 사회적 요인에 의해 당뇨병 환자가 급증하고 있으며, 그 연령층도 중년 및 노년층 뿐만 아니라 청소년층에 까지도 발병되고 있는 실정이다.In recent years, diabetics are rapidly increasing due to dietary changes and complex social factors, and the age group is developing into not only middle-aged and elderly people but also adolescents.
당뇨병은 생체내 인슐린을 분비하는 췌장 β세포의 파괴 혹은 기능저하로 인해 인슐린 분비의 저하 및 유전적 요인이나 비만에 의해 조직내 인슐린 수용체의거부반응으로 혈당이 조직으로 운반되지 않고 소변을 통해 배설되는 대사성질환으로 고혈당, 고당뇨를 주징으로 한다.Diabetes mellitus is excreted through urine without blood sugar being transported to tissue due to a decrease in insulin secretion due to the destruction or dysfunction of pancreatic β-cells secreting insulin in vivo and the rejection of insulin receptors in tissues due to genetic or obesity. Metabolic diseases include high blood sugar and high diabetes.
또한, 당뇨병은 생체내의 당 및 지질대사에 이상을 초래하여 고혈압, 동맥경화증 등의 순환기질환, 신장질환 및 백내장 등의 합병증을 유발한다. 특히, 당뇨병에 의한 혈중 지질구성의 비정상, 즉 혈중 중성지방의 증가, 고밀도지단백 콜레스레롤의 감소 및 저밀도지단백 콜레스테롤의 증가 그리고 지단백의 산화에 의한 지단백 기능의 이상은 혈소판 응집의 증가 및 혈관질환 등의 각종 합병증의 원인으로 알려져 있다.In addition, diabetes causes abnormal metabolism of glucose and lipid metabolism in vivo, causing complications such as circulatory diseases such as hypertension and atherosclerosis, kidney disease and cataracts. In particular, abnormalities in blood lipid composition due to diabetes, such as an increase in triglycerides in blood, a decrease in high-density lipoprotein cholesterol and an increase in low-density lipoprotein cholesterol, and abnormal lipoprotein function due to the oxidation of lipoproteins, can increase platelet aggregation and vascular disease. It is known to cause various complications.
그런데, 최근의 당뇨병 환자들은 주로 고에너지의 식생활과 운동부족에 따른 비만형 당뇨병이 증가하고 있으며, 이에 대한 예방책으로 적당한 에너지 섭취와 운동으로 적당한 체중을 유지하길 권장하고 있다.However, recently, diabetics are increasing obesity-type diabetes mainly due to high-energy diet and lack of exercise, and as a preventive measure, it is recommended to maintain proper weight by proper energy intake and exercise.
그러나, 비만인을 비롯한 당뇨환자들 조차도 급박한 사회적 환경으로 인해 식이에 대한 주의를 간과하는 경우가 많은 실정이다.However, even obese people and diabetics are often overlooked on the diet due to the urgent social environment.
따라서, 본 발명은 상기한 문제점을 해결하기 위한 것으로서, 본 발명의 목적은 혈당 조절의 효과가 있는 생식 식품을 분말형으로 제조하여 당뇨환자(비만인 포함)들이 간편하게 이용하여 복용할 수 있도록 하는 당뇨 환자의 혈당조절 생식식품 및 그 제조방법을 제공하는데 그 목적이 있다.Therefore, the present invention is to solve the above problems, an object of the present invention is to produce a raw food with the effect of blood sugar control in the form of a diabetic patient to be easily taken by diabetics (including obese people) Its purpose is to provide a raw blood sugar control raw foods and a method of manufacturing the same.
상기한 본 발명의 목적을 달성하기 위한 기술적 사상으로써 본 발명은As a technical idea for achieving the above object of the present invention
유기농으로 재배한 원료와 자연에서 채취한 원료 및 기타 원료를 구매한 다음, 상기 유기농으로 재배한 원료와 자연에서 채취한 원료를 동결 건조한다. 상기 동결건조된 원료를 배합 비율에 따라 계량하여 계량된 원료를 분쇄한 다음, 분쇄된 원료를 계량된 기타 원료와 혼합하여 혼합된 원료를 기계 포장한다. 상기 기계포장된 제품을 최종적으로 박스 포장하는 제조공정으로 이루어진 당뇨 환자의 혈당 조절 생식식품 제조방법이 제시된다.The organically grown raw materials, natural raw materials and other raw materials are purchased, and the organically grown raw materials and natural raw materials are lyophilized. The freeze-dried raw material is weighed according to the blending ratio to grind the weighed raw material, and then the mixed raw material is mixed with other weighed raw materials to machine-pack the mixed raw material. The present invention provides a method for producing blood glucose control raw foods for a diabetic patient, which consists of a manufacturing process of finally packaging the machine-packed product.
도 1 내지 도 5는 본 발명에 의한 당뇨환자의 생식식품이 고지방식이에 의한 당뇨병 유발쥐의 혈청 글루코스 함량 및 지질구성에 미치는 영향에 대한 실험결과 데이터를 나타낸 그래프1 to 5 are graphs showing the experimental data on the effect of the reproductive food of diabetic patients according to the present invention on serum glucose content and lipid composition of diabetic rats induced by high fat diet
이하, 본 발명의 실시예에 대한 구성 및 그 작용을 첨부한 도면을 참조하면서 상세히 설명하기로 한다.Hereinafter, with reference to the accompanying drawings, the configuration and operation of the embodiment of the present invention will be described in detail.
먼저, 본 발명에 따른 당뇨환자용 혈당조절 생식식품의 원료성분 및 배합비율에 대하여 아래에 제시된 표 1를 참조하여 설명하기로 한다.First, the ingredients and the blending ratio of the glycemic-controlled raw foods for diabetic patients according to the present invention will be described with reference to Table 1 presented below.
표 1에 제시된 바와 같이 원료성분 및 배합비율을 살펴보면, 곡류(현미:12%, 보리:5%, 수수:2%, 차조:2%, 흰콩:6%, 통밀:2%, 검은깨:0.5%, 검은콩:3%, 미강:7%, 발아현미:6%, 발아율무:8%, 알파현미:14.44%)와, 야채류(당근:0.5%, 우엉:0.3%, 연근:0.3%, 무우:0.9%, 감자:4.5%, 밀순:0.5%, 케일:2%, 명일엽:0.5%, 무우청:0.3%, 유자:1.5%, 호박:3.5%)와, 버섯류(표고버섯:0.7%, 영지버섯:0.2%)과, 해조류(김:0.35, 미역:0.7, 다시마:1.05%)와, 균류(효모:3%, 유산균:0.04%, 클로렐라:1%, 로얄제리:0.5%)와, 약용식물(솔잎:0.3%, 누에:0.2%, 뽕잎:0.8%, 구기자:0.2%, 가시오가피:0.3%)와, 기타(말티톨:6.5%, 볶은소금:0.15%, 비타민A:0.006%, 비타민D3:0.002%, 비타민E:0.008%, 비타민C:0.044%, 비타민B1:0.0014%, 비타민B2:0.0014%, 나이아신:0.0137%, 비타민B6:0.0013%, 엽산:0.0002%, 해조칼슘:1.17%, 젖산철:0.01%, 산화아연:0.012%)로 구성되어 있음을 알 수 있다.As shown in Table 1, the ingredients and blending ratios are as follows: grains (brown rice: 12%, barley: 5%, sorghum: 2%, tea: 2%, white beans: 6%, whole wheat: 2%, black sesame: 0.5) %, Black beans: 3%, rice bran: 7%, germinated brown rice: 6%, germination ratio: 8%, alpha brown rice: 14.44%), vegetables (carrot: 0.5%, burdock: 0.3%, lotus root: 0.3%, Radishes: 0.9%, Potatoes: 4.5%, Wheatgrass: 0.5%, Kale: 2%, Bright leaves: 0.5%, Radish: 0.3%, Citron: 1.5%, Pumpkin: 3.5%), Mushrooms (Shiitake: 0.7%, Ganoderma lucidum mushroom: 0.2%), seaweed (seaweed: 0.35, seaweed: 0.7, kelp: 1.05%), fungus (yeast: 3%, lactic acid bacteria: 0.04%, chlorella: 1%, royal jelly: 0.5%), Medicinal plants (pine needles: 0.3%, silkworms: 0.2%, mulberry leaves: 0.8%, goji berries: 0.2%, spiny ginseng: 0.3%), others (maltitol: 6.5%, roasted salt: 0.15%, vitamin A: 0.006%, vitamin D3: 0.002%, Vitamin E: 0.008%, Vitamin C: 0.044%, Vitamin B1: 0.0014%, Vitamin B2: 0.0014%, Niacin: 0.0137%, Vitamin B6: 0.0013%, Folic acid: 0.0002% , Algae calcium: 1.17%, iron lactate: 0.01%, zinc oxide: 0.012%).
이어서, 본 발명에 따른 당뇨환자용 혈당조절 생식식품의 원료성분 작용(효과)에 대하여 좀 더 구체적으로 살펴보기로 한다.Next, the action (effect) of the raw ingredients of the blood sugar control raw foods for diabetic patients according to the present invention will be described in more detail.
1. 곡류(현미, 보리, 수수, 차조, 흰콩, 통밀, 검은깨, 검은콩, 미강, 발아현미, 발아율무, 알파현미)에 대하여 살펴보기로 한다.1. Let's examine cereals (brown rice, barley, sorghum, green tea, white beans, whole wheat, black sesame seeds, black beans, rice bran, germinated brown rice, germinated brown rice, and alpha brown rice).
곡류는 일반 식사에서 백미, 도정한 곡식을 먹게 되는데, 생식은 모든 곡류를 도정하지 않은 상태에서 동결건조하기 때문에 곡류에서 얻을 수 있는 모든 영양소를 얻을 수 있다.Cereals eat white rice and milled grains in a regular meal. Raw food is freeze-dried without all grains, so all the nutrients that can be obtained from grains can be obtained.
특히, 발아현미와 발아율무는 현미와 율무에 일정한 온도와 수분을 공급하여 싹을 틔운 것으로서 발아 순간에 영양이 가장 높으며, 발아과정에서 소화가 잘되는 상태로 전환 되어지고, 탄수화물, 단백질, 지방 보다 비타민, 효소, 무기질 등의 일반 곡류에서 부족한 특수한 성분을 많이 보강할 수 있다.In particular, germinated brown rice and germinated radish are sprouted by supplying brown rice and germinated radish with a constant temperature and moisture, and are most nutritious at the time of germination, and are converted to a well-digested state during germination, vitamins, enzymes rather than carbohydrates, proteins and fats. It can reinforce many of the special ingredients lacking in general grains such as minerals.
미강은 현미를 백미로 도정하는 과정에서 생기는 쌀의 외피부분과 배아부분만을 모은 것으로서 일반 곡류에서 부족한 지방성분을 보충할 수 있으며, 필수 지방산, 토코페롤, 감마오리자놀, 비타민B군 등을 많이 보강할 수 있다.Rice bran is a collection of only the skin and embryo parts of rice produced in the process of turning brown rice into white rice, which can supplement the fat content that is lacking in general grains, and can reinforce many essential fatty acids, tocopherol, gamma-orizanol, and vitamin B group. have.
곡류는 복합탄수화물이 대략 75%, 단백질이 10%, 지질이 2 ∼ 3% 이하로분포되어 있으며, 여러 곡류를 한꺼번에 섭취하여 각각의 부족되기 쉬운 영양소를 보충할 수 있다.Grains are distributed in approximately 75% of complex carbohydrates, 10% of protein, and 2% to 3% of lipids. The grains can be ingested at one time to replenish nutrients that are likely to be insufficient.
특히, 외피 부분에 많은 식이섬유소와 비타민E, 비타민B군, 칼슘, 인, 철, 칼륨 등의 당 대사에 필요한 영양소가 많이 함유되어 있다.In particular, the outer portion contains a lot of dietary fiber and vitamin E, vitamin B group, calcium, phosphorus, iron, potassium and other nutrients necessary for sugar metabolism.
본 발명에서의 곡류 성분비율은 부분 합계가 67.9% 이며, 성분의 허용범위가 57.94 ∼ 72.94% 범위내에서 배합되어 있다.As for the grain component ratio in this invention, a partial sum total is 67.9%, and the permissible range of a component is mix | blended within the range of 57.94-72.94%.
2. 야채류(당근, 우엉, 연근, 무우, 감자, 밀순, 케일, 명일엽, 무우청, 유자, 호박)와, 버섯류(표고버섯, 영지버섯)에 대하여 살펴보기로 한다.2. Let's take a look at vegetables (carrot, burdock, lotus root, radish, potato, wheatgrass, kale, Myeongil leaf, radish blue, citron, pumpkin) and mushrooms (seed mushroom, ganoderma lucidum).
야채류 및 버섯류는 뿌리, 잎, 줄기, 열매 등의 다양한 식물을 섭취함이 중요하며, 수분이 많고 섬유질과 펙틴질을 함유하여 신체조절작용에 없어서는 안되는 식품이며, 특히 당뇨에는 꼭 필요한 식품이다.Vegetables and mushrooms are important to eat a variety of plants, such as roots, leaves, stems, fruits, and is a food that is indispensable for the body control action, containing a lot of moisture and fiber and pectin, especially foods necessary for diabetes.
또한, 칼슘, 철, 칼륨 등의 무기질을 비롯하여 곡류에서 부족한 비타민A, 비타민B1, 비타민B2, 비타민C 등의 비타민류와 미네랄을 보충할 수 있다.In addition, it is possible to supplement vitamins and minerals such as vitamin A, vitamin B1, vitamin B2, and vitamin C, which are insufficient in grains, including minerals such as calcium, iron, and potassium.
특히, 케일과 명일엽에는 다른 야채에 비해 영양소가 편중되어 있지 않고 골고루 들어 있으며, 단백질의 함량도 풍부하다.In particular, kale and Myeongil leaf are more nutrient-rich than other vegetables, evenly contained, and rich in protein.
야채류 및 버섯류의 특성은 조혈작용, 세포재생작용, 해독작용, 항알레르기작용을 하는 엽록소가 많이 들어 있을 뿐만 아니라 항암, 항균, 항산화, 면역, 혈압, 콜레스테롤, 혈당조절, 소화 등의 약리작용을 하는 식물성 생리활성물질을 함유하고 있다.The characteristics of vegetables and mushrooms include chlorophyll, which is hematopoietic, cell regenerating, detoxifying, and allergic, as well as pharmacological actions such as anticancer, antibacterial, antioxidant, immunity, blood pressure, cholesterol, blood sugar control, and digestion. Contains plant bioactive substances.
특히, 야채류는 시간이 지남에 따라 영양소가 감소됨으로서 수확 즉시 동결건조하여 신선함을 유지함이 중요하다.In particular, it is important that vegetables are lyophilized immediately after harvesting to keep fresh as nutrients are reduced over time.
본 발명에서의 야채류 성분비율은 부분 합계가 14.8% 이며, 성분의 허용범위가 9.8 ∼ 19.8% 범위 내에서 배합되어 있다.As for the vegetable component ratio in this invention, a partial sum is 14.8%, and the permissible range of a component is mix | blended within the range of 9.8-19.8%.
또한, 버섯류의 성분비율은 부분 합계가 0.9% 이며, 성분의 허용범위가 0.4 ∼ 1.4% 범위 내에서 배합되어 있다.In addition, the component ratio of mushrooms is 0.9% in partial sum total, and is mix | blended within the permissible range of a component in 0.4 to 1.4%.
3. 해조류(김, 미역, 다시마)에 대하여 살펴보기로 한다.3. Let's take a look at the seaweed (seaweed, seaweed, kelp).
미역, 다시마는 갈조류이며, 김은 홍조류로서 탄수화물이 50% 정도이며, 특유한 점성 다당류를 함유하고 있다. 또한, 필수 아미노산이 많이 들어 있으며, 요오드, 칼슘, 칼륨, 철분 등의 미네랄이 풍부한 알카리성 식품이다.Seaweed and kelp are brown algae, and seaweed is red algae with about 50% carbohydrate and contains unique viscous polysaccharides. It is also an alkaline food that contains a lot of essential amino acids and is rich in minerals such as iodine, calcium, potassium and iron.
해조류는 야채류와 마찬가지로 엽록소, 식이섬유가 많이 들어 있어 비만, 고혈압에 효험이 있다.Like algae, algae are rich in chlorophyll and dietary fiber, which are effective in obesity and hypertension.
본 발명에서의 해조류 성분비율은 부분 합계가 2.1% 이며, 성분의 허용범위가 1.6 ∼ 2.6% 범위 내에서 배합되어 있다.The partial sum total of the seaweed component ratio in this invention is 2.1%, and is mix | blended within the tolerance range of 1.6-2.6% of a component.
4. 균류(효모, 유산균, 클로렐라, 로얄제리)와, 기타(말티톨, 볶은소금, 비타민A, 비타민D3, 비타민E, 비타민C, 비타민B1, 비타민B2, 비타민B6)에 대하여 살펴보기로 한다.4. Let's look at fungi (yeast, lactic acid bacteria, chlorella, royal jelly) and other (maltitol, roasted salt, vitamin A, vitamin D3, vitamin E, vitamin C, vitamin B1, vitamin B2, vitamin B6).
먼저, 효모는 일반 맥주의 효모와 다른 점은 글루텐과 글루코스가 함유된 배지에서 배양된 효모이며, 열건조 하지 않았기 때문에 발효할 수 있는 활성이 있으며, 단백질 및 다른 영양소를 다른 맥주 효모 보다 많이 얻을 수 있다.First, yeast is different from the brewer's yeast, yeast cultivated in a medium containing gluten and glucose, because it is not heat-dried, fermentable activity, protein and other nutrients can be obtained more than other brewer's yeast have.
또한, 50% 이상의 단백질로 되어 있으며, 비타민B군, 16종의 아미노산, 17종의 비타민, 핵산, 다당류, 미네랄 등이 함유되어 있으며, 특히 혈당조절인자인 GTF-Cr를 함유하고 있어 당뇨에 효과적이다.It is composed of more than 50% protein, contains vitamin B group, 16 amino acids, 17 vitamins, nucleic acids, polysaccharides, minerals, etc., and contains GTF-Cr, a glycemic regulator, which is effective for diabetes. to be.
유산균은 장내에 비타민B군을 생성하기 때문에 인슐린 생성을 증가시키며, 정장작용으로 장내 독소 생산을 억제하고 변비 등의 치료에 도움이 된다.Because lactic acid bacteria produce a group of vitamin B in the intestine, it increases insulin production, and intestinal action inhibits intestinal toxin production and helps treat constipation.
클로렐라는 단백질, 비타민, 미네랄, 지방 그 밖의 영양소가 많이 들어 있는 영양가 높은 건강 식품이며, 베타카로린, 엽록소, 성장촉진인자(CGF) 등에 의해 혈액정화작용, 신진대사촉진 및 인슐린분비능을 왕성하게 하며, 콜레스트롤과 혈압을 저하시키는 작용을 한다.Chlorella is a nutritious, healthy food that is high in protein, vitamins, minerals, fats, and other nutrients.Because of beta-carotene, chlorophyll, growth factor (CGF), chlorella promotes blood purification, metabolism and insulin secretion. It acts to lower cholesterol and blood pressure.
로얄제리는 여왕벌의 전용먹이로 젊은 일벌로부터 소화성이 좋은 로얄제리를 입으로 전달 받는데, 화밀과 화분이 일벌의 몸안에서 한번 소화흡수된 것으로서 단백질, 탄수화물, 지방, 미네랄, 비타민, 효소가 풍부하다.Royal Jelly is a special food for the queen bee, and the young worker bee receives the digestive Royal Jelly from the mouth. The nectar and pollen are digested and absorbed once in the body of the worker bee and are rich in protein, carbohydrates, fats, minerals, vitamins and enzymes.
비타민은 특히 비타민B군이 많이 들어 있어 대사 과정에 관여하며, 성장을 촉진, 당뇨환자들의 체력 보강에 효과적이다.Vitamins, especially in the B-vitamins, are involved in metabolic processes, promote growth, and are effective for improving the stamina of diabetics.
본 발명에서의 균류 성분비율은 부분 합계가 4.5% 이며, 성분의 허용범위가 4.04 ∼ 5.05% 범위 내에서 배합되어 있다.The fungus component ratio in this invention is 4.5% of a partial sum, and is mix | blended within the permissible range of a component in 4.04 to 5.05%.
또한, 기타류의 성분비율은 부분 합계가 7.92% 이며, 성분의 허용범위가 7.92 ∼ 11.42% 범위 내에서 배합되어 있다.In addition, the component ratio of other components is 7.92% in partial sum, and is mix | blended in the permissible range of a component in 7.92 to 11.42%.
5. 약용식물(솔잎, 누에, 뽕잎, 구기자, 가시오가피)에 대하여 살펴 보기로 한다.5. Let's take a look at medicinal plants (pine needles, silkworms, mulberry leaves, gojija, thorn gogapi).
솔잎은 글로코기닌의 성분이 혈당을 강하, 조절한다.Pine needles are a component of glycogen, which lowers and regulates blood sugar.
누에는 이당류를 포도당으로 분해하는 효소인 알파 글루코시데이즈의 활성을 억제함으로서 당분의 흡수와 분해를 저해하여 혈당을 조절한다.Silkworms control the blood glucose by inhibiting the absorption and degradation of sugar by inhibiting the activity of alpha glucosidase, an enzyme that breaks down disaccharides into glucose.
뽕잎은 글루코스데이즈 저해제라고 하는 디옥시노지리마이신, 칼리스테진, 페고민 등의 10여 성분이 들어 있어 혈당을 조절한다.Mulberry leaves contain about 10 ingredients such as deoxynojirimycin, calistine, and pegomin called glucoseday inhibitors to regulate blood sugar.
구기자는 항균, 항암, 면역증진, 간기능 개선, 혈압강하, 당뇨에 효과가 있다.Goji berries are effective in antibacterial, anticancer, immune boosting, liver function improvement, blood pressure lowering, and diabetes.
가시오가피는 엘레우테로시드하는 성분이 혈당을 조절한다.Prickly Pear is a component of eleutheside that regulates blood sugar.
본 발명에서의 약용식물류 성분비율은 부분 합계가 1.8% 이며, 성분의 허용범위가 1.3 ∼ 2.3% 범위 내에서 배합되어 있다.The partial ratio of the medicinal plant component ratio in this invention is 1.8%, and the compoundable range is mix | blended within the range of 1.3 to 2.3%.
이상에서와 같이 본 발명에 의한 원료성분 및 배합비율의 특징을 살펴 보면, 동결건조한 농산물을 기준으로 하여 (곡류) : (야채류, 해조류, 버섯류, 약용식물류) : (균류, 기타)의 비율을 6 ∼ 7 : 2 ∼ 3 : 1 ∼ 2의 비율을 기준하여 배합비율로 정하였다.Looking at the characteristics of the raw material components and the mixing ratio according to the present invention as described above, the ratio of (grains): (vegetables, seaweeds, mushrooms, medicinal plants): (fungi, other) based on the lyophilized agricultural products 6 It was set as the compounding ratio on the basis of the ratio of -7: 2-3: 1-2.
특히, 당뇨환자는 동물성 지방을 제한하여야 하기 때문에 고기류는 넣지 않았다. 그 대신에 단백질의 공급원으로 효모와 같은 균류를 첨가하였다.In particular, diabetics do not include meat because they have to limit animal fats. Instead, fungi such as yeast were added as a source of protein.
또한, 기타 맛을 조정하기 위해 알파현미, 말티톨, 볶은 소금을 첨가 하였으며, 식품에 비타민, 미네랄이 많이 들어 있지만 실험상의 결과를 규격화하기 위하여 비타민류를 첨가 하였다.In addition, alpha brown rice, maltitol, and roasted salt were added to adjust other tastes, and vitamins and minerals were included in food, but vitamins were added to standardize experimental results.
또한, 당뇨환자는 기존 식생활에서 곡류, 야채류에서 얻을 수 있는 영양소가 부족하기 때문에 곡류와 야채율의 비율을 일정하게 지키는 것이 중요하다.In addition, it is important to maintain a constant ratio of cereals and vegetables because diabetics lack the nutrients obtained from cereals and vegetables in the existing diet.
본 발명의 또 다른 특징은 동결건조에 있다. 동결건조는 -40℃ 에서 급속 동결한 다음, 기압을 낮추고 저온 50℃ 이하에서 건조하면 수분은 액상 이동이 되지 않은 얼음의 상태에서 승화되어 제거되기 때문에 원래 모양과 크기를 그대로 유지되며 식품의 맛, 색, 향, 영양, 효소 등의 변화가 적다.Another feature of the invention is in lyophilization. Freeze-drying is rapidly frozen at -40 ℃, then lowered the air pressure and dried at a lower temperature of 50 ℃ or less, so that water is sublimated and removed in the state of ice that has not been transferred to the liquid state, so it retains its original shape and size. Less change in color, flavor, nutrition, enzymes, etc.
건조물에 다시 수분을 공급하면 복원력이 뛰어나 자연상태와 같은 비숫한 상태를 유지할 수 있게 된다. 건조비는 비싸지만 장기 보존이 가능하며, 식품 가공방법 중에 가장 우수한 방법이다.When the building is rehydrated, its resilience is excellent, allowing it to maintain its natural state. Although the drying cost is expensive, long-term preservation is possible and it is the best method among the food processing methods.
이어서, 본 발명에 따른 당뇨환자의 혈당조절 생식식품 복용법에 대하여 살펴보면 다음과 같다.Subsequently, the blood glucose control raw food taking method of the diabetic patient according to the present invention will be described.
복용법은 대용식 혹은 보조식으로 나눌수 있으며, 대용식으로 복용할 경우 식사대신 30g 씩 물이나 주스 200ml에 타서 아침, 저녁으로 먹고, 점심은 일반 식사를 한다.Dosage can be divided into substitutes or supplements. When taking alternatives, take 30g of water or juice 200ml instead of meals for breakfast and dinner, and lunch for regular meals.
보조식으로 복용할 경우 식사전에 15g을 물이나 주스 150ml에 타서 아침, 점심, 저녁으로 복용하면 된다.If you take it as a supplement, take 15g in water or 150ml of juice before breakfast, and take it for breakfast, lunch and dinner.
상기와 같은 복용방법으로 1회에 30 - 40g 을 섭취하여도 식사대용으로 될 수 있는 이유는 동결건조된 식품은 수분을 제거한 양이기 때문에 수분이 있는 생물기준으로 할 경우 동결 건조된 생식은 80g 이상을 섭취하는 것과 동일하다.Even if you take 30-40g at a time with the above-mentioned method, it can be used as a meal replacement. The freeze-dried food is the amount of water removed. Same as ingesting.
화식일 경우 한끼 식사량이 당뇨환자의 경우 800g 정도 섭취하게 되는데 비타민, 미네랄 등의 영양소는 생식 30g 을 섭취하는 것에 비해 적다.In the case of cassowal meal, a meal of about 800g is eaten by diabetic patients, but vitamins, minerals and other nutrients are less than 30g of raw food.
이어서, 당뇨 환자의 혈당조절 효과가 있는 생식 식품의 제조공정에 대하여살펴보기로 한다.Next, the manufacturing process of raw foods having a glycemic control effect in diabetic patients will be described.
유기농으로 재배한 원료와 자연에서 채취한 원료 및 기타 원료를 구매하는 제 1공정과;A first step of purchasing organically grown raw materials, natural raw materials and other raw materials;
상기 각 원료들의 이물질을 제거하고 적당한 크기로 절단하여 동결 건조하는 제 2공정과;A second step of removing foreign matters of each of the raw materials, cutting to a suitable size and freeze drying;
상기 동결건조된 원료를 배합 비율에 따라 계량하는 제 3공정과;A third step of measuring the lyophilized raw material according to a blending ratio;
상기 계량된 원료를 분쇄한 후 계량된 기타 원료와 혼합하는 제 4공정과;A fourth step of pulverizing the weighed raw material and mixing it with other weighed raw materials;
상기 혼합된 원료를 기계 포장한 후, 박스 포장하는 제 5공정으로 이루어진다.After mechanically packing the mixed raw materials, a fifth step of box packaging is performed.
상기 각 제조 공정의 과정을 구체적으로 살펴보면 다음과 같다.Looking at the process of each manufacturing process in detail as follows.
먼저, 유기농으로 재배한 원료(곡류, 야채류)와 자연에서 채취한 원료(해조류, 약용식물 등)와, 기타 원료를 구매한 다음, 유기농으로 재배한 원료와 자연에서 채취한 원료는 이물질을 제거하고 4회 이상 연속 세척한 후, 원료의 종류에 따라 적당한 길이로 절단한다.First, organically grown raw materials (grains, vegetables) and natural raw materials (seaweed, medicinal plants, etc.) and other raw materials are purchased, and organically grown raw materials and natural raw materials are removed from foreign substances. After 4 or more consecutive washes, it cuts into the appropriate length according to the kind of raw material.
절단된 원료를 입상 팬당 제품에 따라 3 ∼ 4kg 를 20 m/m 두께로 균일하게 저편한 다음, 원료에 따라 영하 -30 ∼ -40℃ 에서 10 ∼ 17 시간 정도 동결한다.The cut raw material is uniformly stored at a thickness of 20 m / m in 3 to 4 kg depending on the product per granular pan, and then frozen at -30 to -40 ° C for about 10 to 17 hours depending on the raw material.
급속동결된 원료의 해동을 피하기 위하여 최대한 신속히 건조로에 입관한 다음, 원료에 따라 45 ∼ 50℃에서 22 ∼ 30 시간 내외로 건조하여 건조된 원료가 가습되지 않도록 비닐포장하여 건냉한 장소에 보관한다.In order to avoid thawing of the rapidly frozen raw materials, enter the drying furnace as soon as possible, and then dry them at 45 to 50 ° C for about 22 to 30 hours depending on the raw materials, and pack them in a dry and cool place so that the dried raw materials are not humidified.
동결건조된 원료를 배합 비율에 따라 계량하고 계량된 원료를 분쇄하여 따로계량된 기타 원료와 함께 혼합 한다.The lyophilized raw material is weighed according to the blending ratio and the weighed raw material is ground and mixed with the other weighed raw materials.
혼합된 원료를 15g씩 기계 포장한 다음, 기계 포장된 제품을 박스 포장하여 출고함으로써 본 발명에 따른 당뇨환자용 생식제품의 제조 공정을 완료한다.After 15 g of the mixed raw materials are machine-packed, the machine-packed product is shipped out of the box to complete the manufacturing process of the raw product for diabetic patients according to the present invention.
도 1 내지 도 5는 본 발명에 의한 당뇨환자의 생식식품이 고지방식이에 의한 당뇨병 유발쥐의 혈청 글루코스(Glucose) 함량 및 지질구성에 미치는 영향에 대한 실험결과 데이터를 나타낸 그래프이다.1 to 5 are graphs showing the results of experiments on the effect of the reproductive food of diabetic patients according to the present invention on serum glucose content and lipid composition of diabetic rats induced by high fat diet.
참고로, 본 발명의 실험 연구는 상지대학교 생명과학연구소와 (주)팜리와의 자문연구기관 협약에 의해 수행 되었음을 밝혀두는 바이다.For reference, the experimental research of the present invention will be revealed that the consultation was conducted by Sangji University Life Science Research Institute and the Advisory Research Institute agreement with Palmy Co., Ltd.
본 발명의 실험 연구에 따른 재료 및 방법을 살펴보면 다음과 같다.Looking at the material and method according to the experimental study of the present invention.
1. 실험동물1. Experimental Animal
평균체중이 200±5g 의 Sprague-Dawley종 수컷쥐 50두를 정상군(이하: Nor로 표기), 대조군(당뇨병유발군, 기본식이, 이하:그래프에서 Co로 표기), 특용식이 30%군(당뇨유발균, 70% 기본사료 + 30% 본 발명의 특용식이, 이하:그래프에서 D30으로 표기), 특용식이 50%군(당뇨유발균, 50% 기본식이 + 50% 특용식이, 이하:그래프에서 D50으로 표기), 특용식이 100%(당뇨유발균, 100% 특용식이, 이하:그래프에서 D100으로 표기)의 5개 처리군으로 각각 10두씩 임의 배치하고 환경과 식이에 일주일간의 적응기간을 가졌다.Fifty Sprague-Dawley male rats with an average body weight of 200 ± 5g (hereinafter referred to as Nor), control group (diabetes-induced group, basic diet, hereinafter: labeled as Co in the graph), and special diet group (30%) Diabetic induction, 70% basic feed + 30% The special diet of the present invention, hereinafter: denoted as D30 in the graph, the special diet 50% group (diabetic fungus, 50% basic diet + 50% special diet, below: in the graph D50), a special diet was 100% (diabetes-inducing bacteria, 100% special formula, hereinafter: D100 in the graph) randomly placed 10 dogs each, and had a one-week adaptation period to the environment and diet.
2. 당뇨병유발2. Diabetes Induction
정상군(10두)은 기본식이를 40두의 당뇨병유발군쥐들이 고지방식이를 각각 8주간 급여한 후 12시간의 절식 상태에서 꼬리정맥으로부터 채혈하여 혈당치가250mg/dl 이상임을 확인한 후 당뇨유발쥐로 공시했다. 물론 식이섭취는 자유섭취시켰다.In the normal group (10 heads), 40 diabetic rats fed the high-fat diet for 8 weeks, and collected blood from the tail vein in a 12-hour fasted state to confirm that the blood glucose level was 250 mg / dl or more. As published. Of course, dietary intake was free.
3. 시험식이급여3. Dietary Benefits
시험식이 급여는 전처리군 식이섭취량의 차이가 5%이내로 각 처리군별로 식이 급여 하였으며, 8주간의 당뇨유발 종료시를 기점으로하여 각 처리별 시험식이를 4주간 급여했다. 물은 자유 섭취시켰다.As for the dietary diet, the difference in dietary intake of the pretreatment group was less than 5%, and the dietary benefit was given to each treatment group, and the test diet for each treatment was given for 4 weeks starting from the end of 8 weeks of diabetes induction. Water was taken freely.
4. 체중 및 식이섭취량 측정4. Weight and Dietary Intake
당뇨유발 후 4주간의 시험식이 급여동안 매주 체중을 측정하고 식이섭취량은 매일 급여량과 잔여량으로 계산하였다.Body weight was measured weekly during the test diet for 4 weeks after diabetes induction, and the dietary intake was calculated from the daily intake and the remaining amount.
5. 채혈5. Blood collection
4주간의 시험 식이사육을 마친 후 12시간의 절식상태에서 심장천좌법에 의해 두당 5ml 정도를 채혈하여 공시했다.After 4 weeks of dietary breeding, about 5ml of blood per head was collected by cardiac astronomy at 12 hours of fasting.
6. 시료분석6. Sample Analysis
혈장중성지질, 총콜레스테롤, HDL-콜레스테롤, LDL-콜레스테롤 및 글루코스(Glucose)량은 혈액자동분석기에 의해 분석했다.Plasma neutral lipids, total cholesterol, HDL-cholesterol, LDL-cholesterol and glucose (Glucose) were analyzed by hematology.
먼저, 도 1에 도시된 혈장 중성지방총량의 결과를 살펴보면, 전처리군에서 64.19mg/dl에서 104.91mg/dl의 범위를 나타냈으며, 최고치는 기본식이(Co)만을 급여한 대조군에서, 최저치는 특용식이 100%처리군(D100)에서 보여 주었다.First, looking at the results of the plasma triglycerides shown in Figure 1, the pretreatment group ranged from 64.19mg / dl to 104.91mg / dl, the highest value in the control group fed only the basic diet (Co), the lowest value is applied The diet was shown in the 100% treatment group (D100).
즉, 당뇨병유발군간의 성적을 비교해 보면 특용식이처리군 모두가 대조군 보다 낮은 경향을 보였으며, 특히 특용식이 100%처리군(D100), 특용식이50%처리군(D50)에서는 정상군의 수준을 유지하고 있음을 알 수 있다.In other words, when comparing the results of diabetes-induced group, all of the special dietary treatment group showed lower tendency than the control group. Especially, the special diet was 100% treated group (D100), and the special diet was 50% treated group (D50). It can be seen that.
도 2에 도시된 혈장 총콜레스테롤량의 변동 경향을 살펴 보면, 전 처리군에서 57.40mg/dl에서 112.271mg/dl의 범위를 나타냈으며, 최고치는 기본식이(Co)만을 급여한 대조군에서, 최저치는 당뇨병 특용식이 100%처리군(D100)에서 보여 주었다.Looking at the change in the total plasma cholesterol level shown in Figure 2, in the pre-treatment group ranged from 57.40 mg / dl to 112.271 mg / dl, the highest value in the control group fed only the basic diet (Co), the lowest value Diabetic special diet was shown in the 100% treatment group (D100).
당뇨병유발군간에서는 대조군, 특용식이 30%처리군(D30)에는 유의한 차이를 나타내지 않았으나, 특용식이 50% 처리군(D50), 특용식이 100% 처리군(D100)에서는 대조군보다 낮은 값을 나타내었다.In the diabetic group, the control group and the special diet did not show a significant difference in the 30% treated group (D30), but the special formula in the 50% treated group (D50) and the special diet in the 100% treated group (D100) showed lower values than the control group. .
일반적으로, 당뇨유발시에 혈장 콜레스테롤량이 증가하는데 본 발명의 실험 결과에서도 당뇨유발군으로 기본식이만을 급여한 대조군에서 가장 높은 총콜레스테롤 수치를 나타남을 알 수 있다.In general, the amount of plasma cholesterol increases during diabetes-induced diabetes. In the experimental results of the present invention, it can be seen that the highest total cholesterol level is shown in the control group fed only the basic diet as the diabetes-induced group.
도 3에 도시된 HDL-콜레스테롤량의 변동 경향을 살펴보면, 전 처리군에서 30mg/dl 대의 수치를 나타냈으며, 최고치는 특용식이 50%처리군(D50)에서, 최저치는 특용식이 100%처리군(D100)에서 보여 주었다.Looking at the trend of the variation in the amount of HDL-cholesterol shown in Figure 3, the pretreatment group showed a value of 30 mg / dl, the maximum value in the special formula 50% treatment group (D50), the lowest value in the special formula 100% treatment group ( D100).
일반적으로, HDL-콜레스테롤은 혈관의 내적 상태를 개선 시킨다는 점을 고려해 볼때 당뇨병의 합병증으로 일어날 수 있는 순환계 질환을 개선하기 위해서는 높은 수치가 바람직하다.In general, considering that HDL-cholesterol improves the internal condition of blood vessels, high levels are desirable to improve circulatory diseases that can occur as a complication of diabetes.
도 4에 도시된 LDL-콜레스테롤량의 변동치를 살펴보면, 전 처리군에서 49.50mg/dl에서 72.30mg/dl의 범위를 나타냈으며, 최고치는 특용식이 50%처리군(D50)에서, 최저치는 특용식이 100%처리군(D100)에서 보여 주었다.Looking at the variation in LDL-cholesterol amount shown in Figure 4, the range of 49.50 mg / dl to 72.30 mg / dl in the pre-treatment group, the maximum value is the special formula in the 50% treatment group (D50), the minimum value is the special diet 100% treated group (D100).
본 발명의 실험 결과에 따르면, 고지방식이에 의해 당뇨를 유발하는 과정에서 유도된 LDL-콜레스테롤량이 저에너지식이인 특용식이 처리에도 불구하고 저하하지 않고, 특용식이 100%처리군(D100)을 제외한 다른 처리군에서 LDL-콜레스테롤량이 대조군과 유사한 수치를 보였다.According to the experimental results of the present invention, the amount of LDL-cholesterol induced in the process of inducing diabetes by the high-fat diet does not decrease despite the low-energy special dietary treatment, and the special diet except the 100% treatment group (D100) The LDL-cholesterol content in the treated group was similar to that of the control group.
그러나, 특용식이 100%처리군(D100)에는 LDL-콜레스테롤의 급격한 저하를 나타내어 정상군의 수준을 유지하였다.However, in the special diet 100% treated group (D100), the LDL-cholesterol showed a sharp drop, maintaining the level of the normal group.
도 5에 도시된 혈중 글루코스(Glucose)량의 변동치를 살펴보면, 당뇨유발군 모두가 정상군 보다 높은 수치를 나타냈다. 이러한 결과는 고지방식이의 급여에 의해 유발된 고혈당이 지속되었기 때문이다.Looking at the variation in the amount of glucose in the blood (Glucose) shown in Figure 5, all of the diabetes-induced group showed a higher value than the normal group. This result is due to the continued high blood sugar caused by high-fat diets.
당뇨유발군에서는 특용식이 처리군 모두가 대조군 보다 낮은 경향을 보였으며, 특히 특용식이 30%처리군(D30), 50%처리군(D50) 및 100%처리군(D100)들 모두가 대조군 보다 유의한 감소를 보여 특용식이의 혈당강하 효과가 있다는 것을 알 수 있다.In the diabetes-induced group, all of the special diet-treated groups showed lower tendency than the control group, and especially, the special diets of the 30% treated group (D30), 50% treated group (D50), and 100% treated group (D100) were significantly higher than the control group. One reduction shows that there is a hypoglycemic effect of the diet.
이상에서와 같이, 본 발명에 의한 당뇨환자용 특용식이 식품을 이용하여 고지방식이에 의한 당뇨병 유발쥐의 혈청 Glucose 함량 및 지질구성에 미치는 영향에 대한 실험데이터의 최종 결과는 다음과 같다.As described above, the final results of the experimental data on the effect on the serum Glucose content and lipid composition of diabetic rats induced by high-fat diet using the dietary foods for diabetic patients according to the present invention are as follows.
1). 당뇨유발 후 28일동안 각 처리별 식이를 급여한 결과, 정상군에서는 체중이 증가 하였으나, 당뇨유발군 모두에서 감소했다. 당뇨유발군중에서는 특용식이 100% 처리군에서 체중감소가 제일 많았다.One). After 28 days of diabetes mellitus, the diets of each treatment resulted in weight gain in the normal group, but decreased in all diabetic groups. Among the diabetic group, weight loss was the most common in the 100% treated group.
2). 혈장 중성지방총량은 대조군과 비교하여 특용식이 50%처리군, 100%처리군에서 하락하는 경향을 보여 주였다. 특히 특용식이 50%처리군, 100%처리군에서는 정상군의 수준을 보여 주였다.2). Plasma triglycerides tended to decrease in the 50% and 100% treatment groups compared to the control group. In particular, the special formula showed the level of the normal group in the 50% treatment group and 100% treatment group.
3). 혈장 콜레스테롤은 대조군과 비교하여 특용식이 50%처리군, 100%처리군에서 하락하는 경향을 보여 주였다.3). Plasma cholesterol showed a tendency to drop in the special diet 50% treated group, 100% treated group compared to the control group.
4). HDL-콜레스테롤량은 전 처리군에서 30 mg/dl 대의 수치를 나타내었으며, 각 처리에 따라 일정한 변동경향을 볼 수 없었다.4). The amount of HDL-cholesterol showed a value of 30 mg / dl in the pretreatment group, and there was no change in the trend of each treatment.
5). LDL-콜레스테롤량은 특용식이 100% 처리군에서 최저치를 나타내어 정상군의 수준을 나타내었으며, 여타 처리군들은 대조군과 유사한 수치를 나타내었다.5). The amount of LDL-cholesterol was the lowest in the 100% treated group, and the level of the normal group was shown. The other treated groups showed similar values as the control group.
6). 혈장 글루코스량은 특용식이 처리군 모두가 대조군 보다 낮은 경향을 나타냈다. 특히 특용식이 100% 처리군에서는 120 mg/dl의 수치를 나타내어 정상수준의 범주였다.6). Plasma glucose amount tended to be lower than that in the control diet group. In particular, in the 100% treated group, the special diet showed 120 mg / dl, which was a normal range.
이상에서와 같이, 본 발명에 의한 당뇨 환자의 혈당조절 생식식품 및 그 제조방법에 따르면 다음과 같은 효과가 있다.As described above, according to the blood glucose control raw foods and manufacturing method of the diabetic patient according to the present invention has the following effects.
첫째, 40여가지의 다양한 식품 섭취를 통해 다양한 영양소(탄수화물 70%, 다백질 15%, 지방 5%)를 공급받을 수 있으며, 이 때 공급받을 수 있는 다양한 비타민, 미네랄(비타민C, 비타민E, 비타민B - 복합체, 마그네슘, 크롬, 아연 등)은 신진 대사를 원활하게 할 뿐만 아니라 인슐린의 작용을 도울 수 있다.First, it is possible to receive a variety of nutrients (70% carbohydrate, 15% protein, 5% fat) through the intake of about 40 different foods, and various vitamins and minerals (vitamin C, vitamin E, B-complexes, magnesium, chromium, and zinc) can help metabolism and help insulin work.
둘째, 정제하지 않고 조리 과정을 최소한한 통곡식과 콩류, 야채 중심으로 만들어진 생식은 복합탄수화물과 식이섬유가 많이 들어있어 포도당이 혈류로 방출되는 것을 조절함으로서 인슐린의 대한 요구가 줄여 준다.Second, raw foods made from whole grains, legumes, and vegetables that minimize the cooking process without purification contain a lot of complex carbohydrates and fiber, reducing the need for insulin by controlling the release of glucose into the bloodstream.
셋째, 주로 식품성 식품들로 되어 있어 저콜레스트롤, 저지방 등의 저열량 식품으로 혈당이 높아지는 것을 막을 수 있다.Third, it is mainly made of food-based foods, such as low cholesterol, low fat calorie foods can prevent the blood sugar rises.
넷째, 열을 가하지 않고 일체의 조리, 가공을 하지 않은 생식이기 때문에 열을 가하여 요리하여 먹는 식품(화식) 보다 영양소, 효소 등의 성분의 변화가 거의 없어 화식으로 먹을 때 보다 적은 양을 먹어도 영양소의 섭취가 충분하다. 따라서, 과식으로 인한 비만을 해결할 수 있다.Fourth, since raw food is not cooked or processed without any heat, there is almost no change in nutrients, enzymes, etc. than foods cooked with heat, so even if you eat less than you eat with food, Intake is enough. Therefore, obesity due to overeating can be solved.
다섯째, 유기농, 무농약으로 재배한 농산물을 사용하여 농약, 화학비료 등의 불필요한 노폐물의 부담이 적고, 환경독소물질로 부터 몸을 보호할 수 있다.Fifth, using agricultural products grown with organic and pesticide-free, less burden of unnecessary waste such as pesticides, chemical fertilizers, and can protect the body from environmental toxins.
여섯째, 나트륨 함량이 적어 일반 식사를 하는 것 보다 나트륨의 섭취가 제한된다.Sixth, the sodium content is less than the normal meal intake of sodium.
일곱째, 생식은 각 식품에 들어 있는 모든 영양성분을 그대로 얻을 수 있을 뿐만아니라 식품에 들어 있는 효소를 얻을 수 있어 소화효소를 분비해야 되는 췌장에 부담을 줄여 인슐린의 분비에 도움을 줄 수 있다.Seventh, reproduction can not only get all the nutrients contained in each food, but also the enzymes in the food can reduce the burden on the pancreas to secrete digestive enzymes can help the secretion of insulin.
여덟째, 식품첨가물이 일체 들어 있지 않다. 따라서, 자연의 맛을 살리고 계속적으로 먹어도 질리지 않게 된다.Eighth, no food additives are contained. Therefore, even if you take advantage of the natural flavor and continue to eat.
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2000-0052140A KR100439748B1 (en) | 2000-09-04 | 2000-09-04 | The uncooked food for glucose control of a diabetic and method of manufacture |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2000-0052140A KR100439748B1 (en) | 2000-09-04 | 2000-09-04 | The uncooked food for glucose control of a diabetic and method of manufacture |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20020018844A true KR20020018844A (en) | 2002-03-09 |
KR100439748B1 KR100439748B1 (en) | 2004-07-12 |
Family
ID=19687222
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR10-2000-0052140A KR100439748B1 (en) | 2000-09-04 | 2000-09-04 | The uncooked food for glucose control of a diabetic and method of manufacture |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100439748B1 (en) |
Cited By (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20020025143A (en) * | 2002-03-05 | 2002-04-03 | 김수경 | The uncooked food for care fatty liver and method thereof |
KR20020037004A (en) * | 2002-04-22 | 2002-05-17 | 김수경 | The freeze drying soloid uncooked food and manufacturing method thereof |
KR20020071152A (en) * | 2001-03-05 | 2002-09-12 | 정풍한방제약주식회사 | Functional food composition and a process thereof |
KR20020086372A (en) * | 2002-10-01 | 2002-11-18 | 주식회사 이롬라이프 | Composition for suppressing hyperlipidemia containing grains, fruits and vegetables, seeweeds and mushrooms |
KR20030005086A (en) * | 2002-11-08 | 2003-01-15 | 주식회사 이롬라이프 | Diet composition containing freeze-dried uncooked food and dietary fiber |
KR20030044273A (en) * | 2001-11-29 | 2003-06-09 | 우병하 | A composition for lowering the blood sugar level |
KR20030070933A (en) * | 2002-02-27 | 2003-09-03 | 박동기 | solid or fluid type functional food and its manufacturing method |
KR20030078248A (en) * | 2002-03-28 | 2003-10-08 | 고을빛 생식마을 (주) | A Tonic Composition for Improvement of Sexual Function Using Natural Fresh Food |
KR20030079190A (en) * | 2002-04-02 | 2003-10-10 | 고을빛 생식마을 (주) | A Tonic Composition for Complementation of Nutrition for Pregnant Woman Using Natural Food |
KR20040026734A (en) * | 2002-09-25 | 2004-04-01 | 백철언 | A new methods for the production of nuclotide yeast composition of eating uncooked cookie |
KR20040032288A (en) * | 2002-10-09 | 2004-04-17 | 서경석 | Health food comprising natural Ganoderma Lucidum Karst components and method for the same |
KR20040084043A (en) * | 2003-03-26 | 2004-10-06 | 오수형 | Manufacturing process for raw grains and vegetables foods |
KR100481314B1 (en) * | 2002-02-15 | 2005-04-07 | 주식회사 삼화한양식품 | The biscuit type raw food and the manufacturing method of that |
KR100485515B1 (en) * | 2002-09-27 | 2005-04-27 | 주식회사 지엔에프 | Manufacturing method of health food with mulberry leaves |
KR100496019B1 (en) * | 2002-07-19 | 2005-06-16 | 대한민국 | γ-oryzanol with reducing effect on blood glucose level |
KR100756858B1 (en) * | 2001-12-11 | 2007-09-07 | 씨제이 주식회사 | Uncooked food and manufacturing method thereof |
KR100814327B1 (en) * | 2006-10-09 | 2008-03-18 | 정금희 | a health-supporting food for control of body weight and its preparation method |
KR100854403B1 (en) * | 2007-05-08 | 2008-08-26 | 한국식품연구원 | Diet food comprising citron seed extract |
KR101453062B1 (en) * | 2013-03-27 | 2014-10-23 | 김용욱 | Ferment solution and pill using silkworm and manufacturing method of that |
KR101455252B1 (en) * | 2012-07-31 | 2014-10-31 | 표재호 | Containing extract of medicinal crops and manufacturing thereof |
CN104223053A (en) * | 2013-06-20 | 2014-12-24 | 唐贝宁医药科技(北京)有限公司 | Novel functional food for synchronously reducing hyperglycaemia, hypertension and hyperlipidemia |
CN104273535A (en) * | 2014-10-11 | 2015-01-14 | 中山百鸥医药科技有限公司 | Natural health food |
KR101520860B1 (en) * | 2014-10-21 | 2015-05-15 | 주식회사 아이웰 | Manufacturing method of functional food for improving and preventing diabetes mellitus using the balsam pear by main material |
WO2017200311A1 (en) * | 2016-05-18 | 2017-11-23 | 주식회사 넥스 | Food composition containing dried wheat grass powder for slimming and immunopotentiating |
CN109156734A (en) * | 2018-09-23 | 2019-01-08 | 李红光 | A kind of nutrient rice milk that can be hypoglycemic |
KR20230092444A (en) | 2021-12-17 | 2023-06-26 | 한국한의약진흥원 | Composition for preventing or treating obesity or diabetes mellitus comprising lotus root extract as an active ingredient |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100840876B1 (en) | 2006-12-04 | 2008-06-24 | 유한회사원탑무역 | a citron tea and process for preparation thereof |
KR101091596B1 (en) * | 2009-01-08 | 2011-12-13 | 건국대학교 산학협력단 | Eyesight protective composition comprising functional ingredients for prevention and treatment of diabetes mellitus and diabetic complication |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20000007053A (en) * | 1999-11-22 | 2000-02-07 | 주육현 | Method for manufacturing silk raw food containing silk amino acid and peptide element |
-
2000
- 2000-09-04 KR KR10-2000-0052140A patent/KR100439748B1/en active IP Right Grant
Cited By (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20020071152A (en) * | 2001-03-05 | 2002-09-12 | 정풍한방제약주식회사 | Functional food composition and a process thereof |
KR20030044273A (en) * | 2001-11-29 | 2003-06-09 | 우병하 | A composition for lowering the blood sugar level |
KR100756858B1 (en) * | 2001-12-11 | 2007-09-07 | 씨제이 주식회사 | Uncooked food and manufacturing method thereof |
KR100481314B1 (en) * | 2002-02-15 | 2005-04-07 | 주식회사 삼화한양식품 | The biscuit type raw food and the manufacturing method of that |
KR20030070933A (en) * | 2002-02-27 | 2003-09-03 | 박동기 | solid or fluid type functional food and its manufacturing method |
KR20020025143A (en) * | 2002-03-05 | 2002-04-03 | 김수경 | The uncooked food for care fatty liver and method thereof |
KR20030078248A (en) * | 2002-03-28 | 2003-10-08 | 고을빛 생식마을 (주) | A Tonic Composition for Improvement of Sexual Function Using Natural Fresh Food |
KR20030079190A (en) * | 2002-04-02 | 2003-10-10 | 고을빛 생식마을 (주) | A Tonic Composition for Complementation of Nutrition for Pregnant Woman Using Natural Food |
KR20020037004A (en) * | 2002-04-22 | 2002-05-17 | 김수경 | The freeze drying soloid uncooked food and manufacturing method thereof |
KR100496019B1 (en) * | 2002-07-19 | 2005-06-16 | 대한민국 | γ-oryzanol with reducing effect on blood glucose level |
KR20040026734A (en) * | 2002-09-25 | 2004-04-01 | 백철언 | A new methods for the production of nuclotide yeast composition of eating uncooked cookie |
KR100485515B1 (en) * | 2002-09-27 | 2005-04-27 | 주식회사 지엔에프 | Manufacturing method of health food with mulberry leaves |
KR20020086372A (en) * | 2002-10-01 | 2002-11-18 | 주식회사 이롬라이프 | Composition for suppressing hyperlipidemia containing grains, fruits and vegetables, seeweeds and mushrooms |
KR20040032288A (en) * | 2002-10-09 | 2004-04-17 | 서경석 | Health food comprising natural Ganoderma Lucidum Karst components and method for the same |
KR20030005086A (en) * | 2002-11-08 | 2003-01-15 | 주식회사 이롬라이프 | Diet composition containing freeze-dried uncooked food and dietary fiber |
KR20040084043A (en) * | 2003-03-26 | 2004-10-06 | 오수형 | Manufacturing process for raw grains and vegetables foods |
KR100814327B1 (en) * | 2006-10-09 | 2008-03-18 | 정금희 | a health-supporting food for control of body weight and its preparation method |
KR100854403B1 (en) * | 2007-05-08 | 2008-08-26 | 한국식품연구원 | Diet food comprising citron seed extract |
KR101455252B1 (en) * | 2012-07-31 | 2014-10-31 | 표재호 | Containing extract of medicinal crops and manufacturing thereof |
KR101453062B1 (en) * | 2013-03-27 | 2014-10-23 | 김용욱 | Ferment solution and pill using silkworm and manufacturing method of that |
CN104223053A (en) * | 2013-06-20 | 2014-12-24 | 唐贝宁医药科技(北京)有限公司 | Novel functional food for synchronously reducing hyperglycaemia, hypertension and hyperlipidemia |
CN104273535A (en) * | 2014-10-11 | 2015-01-14 | 中山百鸥医药科技有限公司 | Natural health food |
KR101520860B1 (en) * | 2014-10-21 | 2015-05-15 | 주식회사 아이웰 | Manufacturing method of functional food for improving and preventing diabetes mellitus using the balsam pear by main material |
WO2017200311A1 (en) * | 2016-05-18 | 2017-11-23 | 주식회사 넥스 | Food composition containing dried wheat grass powder for slimming and immunopotentiating |
CN109156734A (en) * | 2018-09-23 | 2019-01-08 | 李红光 | A kind of nutrient rice milk that can be hypoglycemic |
KR20230092444A (en) | 2021-12-17 | 2023-06-26 | 한국한의약진흥원 | Composition for preventing or treating obesity or diabetes mellitus comprising lotus root extract as an active ingredient |
Also Published As
Publication number | Publication date |
---|---|
KR100439748B1 (en) | 2004-07-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100439748B1 (en) | The uncooked food for glucose control of a diabetic and method of manufacture | |
CN102228242A (en) | Compound vegetable healthcare product and method for preparing same | |
WO2006016701A1 (en) | Agent for preventing/ameliorating diabetes and functional food for preventing/ameliorating diabetes | |
KR100927834B1 (en) | A method for producing color caramelized rice cake and a colored caramelized rice cake produced by the above method | |
CN103005450A (en) | Nutrient fast-food convenient food and preparation method thereof | |
CN108477609A (en) | A kind of burdock weight losing meal-replacing stick and preparation method thereof | |
CN108378263A (en) | A kind of nutritious food packet | |
CN104336490A (en) | Food for tonifying brain and promoting intelligence growth and production method of food | |
KR101386259B1 (en) | Functional food compositon for reducing body weight and improving metabolic syndrome and manufacturing method of the same | |
KR20150077483A (en) | Sunshik Using Material of White and Black Food and Manufacturing Method Thereof | |
KR20110014421A (en) | A nature spice | |
KR20020025143A (en) | The uncooked food for care fatty liver and method thereof | |
CN111406941A (en) | Nutritional dietary compositions and edible products | |
CN103750156B (en) | Dried eucommia bark noodles and the application in prevention and therapy hypertension thereof | |
KR20110014418A (en) | A hot spice | |
CN108272088A (en) | Special diet for labour packet | |
CN113841884A (en) | Formula of instant meal replacement powder for improving nutrient metabolism and preparation method thereof | |
JP2000166499A (en) | Health food with blended hericium erinaceum | |
KR102035272B1 (en) | Energy bars and a method of manufacturing the same diet that utilizes the edivle insect | |
CN111406940A (en) | Dietary fiber composition and edible product | |
KR101195316B1 (en) | High a-Glucosidase Inhibitors Gochujang | |
CN105249221A (en) | Pumpkin and purple yam food and making method thereof | |
KR101547576B1 (en) | Method of preparing functional functional grain | |
CN108850380A (en) | A kind of formula and preparation method of Chinese wolfberry and coffee | |
Nwawuba et al. | A Comparative Study on The Effect of Cooking Methods on The Nutritional Contents of Ripe and Unripe Plantain (Musa Paradisiaca) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
N231 | Notification of change of applicant | ||
E902 | Notification of reason for refusal | ||
AMND | Amendment | ||
E601 | Decision to refuse application | ||
J201 | Request for trial against refusal decision | ||
AMND | Amendment | ||
E902 | Notification of reason for refusal | ||
B701 | Decision to grant | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20130430 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20140430 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20150429 Year of fee payment: 12 |
|
FPAY | Annual fee payment |
Payment date: 20160426 Year of fee payment: 13 |
|
FPAY | Annual fee payment |
Payment date: 20190411 Year of fee payment: 16 |